Óscar Navarro-Montero

Author

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research

Also Known As

O Navarro-Montero, O. Navarro-Montero, Oscar Navarro-Montero, Óscar Navarro-Montero

Publications

463

Citations

H-Index

Concepts

All Affiliations

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research Josep Carreras Leukaemia Research Institute Institució Catalana de Recerca i Estudis Avançats Universitat de Barcelona Universidad de Granada

ÓN

About

Óscar Navarro-Montero is an author at Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research specializing in cell biology, medicine, and developmental biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	109
2	Cell Biology	3	3	109
3	Immunology	2	2	81
4	Health Sciences	1	1	28
5	Autoimmunity	1	1	53

Óscar Navarro-Montero

Publications

425

Citations

H-Index

Page 1

	Year	Citations
HOXA9 promotes hematopoietic commitment of human embryonic stem cells Verónica Ramos–Mejía, Óscar Navarro-Montero, Verónica Ayllón, Blood	2014	104
Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function Damià Romero–Moya, Clara Bueno, Rosa Montes, Haematologica	2013	83
SCL/TAL1 Regulates Hematopoietic Specification From Human Embryonic Stem Cells Pedro J. Real, Gertrudis Ligero, Verónica Ayllón, Molecular Therapy	2012	66
The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fate Verónica Ayllón, Clara Bueno, Verónica Ramos–Mejía, Leukemia Human Hematoendothelial ProgenitorsDevelopmental BiologyLymphocyte DevelopmentImmunologyHematology	2015	53
FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs Clara Bueno, Verónica Ayllón, Rosa Montes, Blood	2013	40
SCL/TAL1-mediated Transcriptional Network Enhances Megakaryocytic Specification of Human Embryonic Stem Cells Miguel G. Toscano, Óscar Navarro-Montero, Verónica Ayllón, Molecular Therapy Hdac InhibitorsBlood CellHdac InhibitorMyeloid NeoplasiaTranscriptional Regulation	2014	28
Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells Rosa Montes, Verónica Ayllón, Cristina Prieto, Leukemia Ligand-independent Flt3 ActivationCell InteractionImmunologyBlood CellCord Blood	2013	28
<i>RUNX1c</i>Regulates Hematopoietic Differentiation of Human Pluripotent Stem Cells Possibly in Cooperation with Proinflammatory Signaling Óscar Navarro-Montero, Verónica Ayllón, Mar Lamolda, Stem Cells	2017	23

Page 1